http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2598736-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_357e17616929a711891e31f6a80d107a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-48 |
| filingDate | 2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53bdc8a84eb6f102542503da80603f70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9eb305b126c85b6c504b48d2eb39cf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce5d3addd177503183712ef5f0cf38f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41eaac261b55659728abd58e55c48af9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_940ce2b8f8e2de5ba9b477d83abb8072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f824eae70a4588ec7881236843200b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1854118939be454a1a7db2028f40b5 |
| publicationDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2598736-C2 |
| titleOfInvention | Method for microencapsulation of sertoli cells, produced microcapsules and use thereof for preventing and treating sugar diabetes type 1 |
| abstract | FIELD: medicine. n SUBSTANCE: group of inventions refers to medicine, particularly to endocrinology, and describes method of producing microcapsules based on hydrogel containing Sertoli cells (SC), microcapsules containing SC, and application of microcapsules based on hydrogel containing SC. Method is characterised by obtaining homogeneous suspension SC, which purity in cell composition is more than 90 %, in salted solution of super pure sodium alginate in concentration from 1 to 5 % wt/Vol, sucked off suspension at rate of 10-60 ml/min, and suspension is introduced in needle-shaped element, produced by means of fluid flow generator, where said fluid is air is extrusion of suspension inside needle-shaped element by means of discharge of fluid medium flow rate of 3-7 l/min, as result of which continuous flow of micro drops having identical dimensions, introduction of micro drops flow in water solution containing bivalent cations or polycationic substance, which leads to gel formation and production of microcapsules, whose size is equal to 300-500 mqm. n EFFECT: microcapsules based on hydrogel containing SC, are used for prevention and/or treatment of type 1 diabetes mellitus (DM T1). n 7 cl, 9 dwg |
| priorityDate | 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.